{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:37:53Z","timestamp":1791581873040,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ophtha.2018.06.017","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T11:01:25Z","timestamp":1533294085000},"page":"1874-1885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Oral Memantine for the Treatment of Glaucoma"],"prefix":"10.1016","volume":"125","author":[{"given":"Robert N.","family":"Weinreb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Liebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-6202","authenticated-orcid":false,"given":"Ivan","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-615X","authenticated-orcid":false,"given":"James D.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Zangwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh","family":"Badger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bejanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2018.06.017_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2018.06.017_bib2","series-title":"Preferred Practice Pattern in Primary Open-Angle Glaucoma","year":"2015"},{"key":"10.1016\/j.ophtha.2018.06.017_bib3","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.06.017_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.06.017_bib8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archopht.117.11.1540","article-title":"Is neuroprotection a viable therapy for glaucoma?","volume":"117","author":"Weinreb","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(92)90598-X","article-title":"Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity","volume":"219","author":"Siliprandi","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-8993(91)90944-Q","article-title":"Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture","volume":"551","author":"Sucher","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.ophtha.2018.06.017_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00001756-199009000-00009","article-title":"Redox modulation of NMDA receptor-mediated Ca2+ flux in mammalian central neurons","volume":"1","author":"Sucher","year":"1990","journal-title":"Neuroreport"},{"key":"10.1016\/j.ophtha.2018.06.017_bib12","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/S0042-6989(97)00047-3","article-title":"Molecular basis of glutamate toxicity in retinal ganglion cells","volume":"37","author":"Sucher","year":"1997","journal-title":"Vision Res"},{"key":"10.1016\/j.ophtha.2018.06.017_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/eye.2012.84","article-title":"Evaluation of corpus geniculatum laterale and vitreous fluid by magnetic resonance spectroscopy in patients with glaucoma; a preliminary study","volume":"26","author":"Doganay","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2018.06.017_bib14","first-page":"1940","article-title":"Concurrent downregulation of a glutamate transporter and receptor in glaucoma","volume":"41","author":"Naskar","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004240050660","article-title":"Transport-mediated release of endogenous glutamate in the vertebrate retina","volume":"436","author":"Maguire","year":"1998","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ophtha.2018.06.017_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00221-009-1896-0","article-title":"Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma","volume":"197","author":"Park","year":"2009","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.ophtha.2018.06.017_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.1997.sp021909","article-title":"Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism","volume":"499","author":"Chen","year":"1997","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0028-3908(98)00161-0","article-title":"Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in\u00a0vitro and in\u00a0vivo characterization","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"issue":"Suppl 3","key":"10.1016\/j.ophtha.2018.06.017_bib19","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1016\/S0039-6257(01)00200-4","article-title":"Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey","volume":"45","author":"Hare","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib20","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1167\/iovs.03-0566","article-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: functional measures","volume":"45","author":"Hare","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib21","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1167\/iovs.03-0567","article-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: structural measures","volume":"45","author":"Hare","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00061198-200212000-00003","article-title":"Neuroprotective effect of memantine in different retinal injury models in rats","volume":"11","author":"WoldeMussie","year":"2002","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2018.06.017_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archopht.118.3.378","article-title":"Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma","volume":"118","author":"Y\u00fccel","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archopht.117.1.24","article-title":"Comparison of conventional and high-pass resolution perimetry in a prospective study of patients with glaucoma and healthy controls","volume":"117","author":"Chauhan","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib26","series-title":"Perimetry Update 1990\/1991","article-title":"Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: Statpac 2","author":"Heijl","year":"1991"},{"key":"10.1016\/j.ophtha.2018.06.017_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ajo.2005.04.044","article-title":"Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders","volume":"140","author":"Parrish","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib28","first-page":"1563","article-title":"The current research status of normal tension glaucoma","volume":"9","author":"Mi","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ophtha.2018.06.017_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40263-013-0077-7","article-title":"The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer\u2019s disease taking cholinesterase inhibitors","volume":"27","author":"Grossberg","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ophtha.2018.06.017_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/WNF.0b013e3181ebd109","article-title":"A\u00a0pilot efficacy and tolerability trial of memantine for essential tremor","volume":"33","author":"Handforth","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNF.0b013e318184fae2","article-title":"Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation","volume":"32","author":"Keck","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/1352458510367662","article-title":"Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial","volume":"16","author":"Lovera","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2018.06.017_bib33","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.clinthera.2005.10.006","article-title":"Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide\/metformin in healthy young subjects: a single-center, multiple-dose, open-label study","volume":"27","author":"Rao","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2018.06.017_bib34","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000342388.73185.80","article-title":"Memantine induces reversible neurologic impairment in patients with MS","volume":"72","author":"Villoslada","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2018.06.017_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200211000-00005","article-title":"A\u00a0double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)","volume":"17","author":"Wilcock","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.exer.2015.07.004","article-title":"A\u00a0framework to explore the visual brain in glaucoma with lessons from models and man","volume":"141","author":"Yucel","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2018.06.017_bib38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2016.02.017","article-title":"Risk of visual field progression in glaucoma patients with progressive retinal nerve fiber layer thinning: a 5-year prospective study","volume":"123","author":"Yu","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.06.017_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.6.4.11","article-title":"Reducing variability of perimetric global indices from eyes with progressive glaucoma by censoring unreliable sensitivity data","volume":"6","author":"Pathak","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib40","article-title":"Segmented inner plexiform layer thickness as a potential biomarker to evaluate open-angle glaucoma: dendritic degeneration of retinal ganglion cell","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2018.06.017_bib41","doi-asserted-by":"crossref","first-page":"BI020","DOI":"10.1167\/iovs.17-21987","article-title":"Biomarkers and surrogate endpoints: lessons learned from glaucoma","volume":"58","author":"Medeiros","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajo.2017.07.011","article-title":"Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study","volume":"182","author":"Shoji","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib43","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2017.04.021","article-title":"24-2 Visual fields miss central defects shown on 10-2 tests in glaucoma suspects, ocular hypertensives, and early glaucoma","volume":"124","author":"De Moraes","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.06.017_bib44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1167\/iovs.17-22855","article-title":"Mesenchymal stem cell-derived small extracellular vesicles promote neuroprotection in rodent models of glaucoma","volume":"59","author":"Mead","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010237","article-title":"Anesthetic preconditioning as endogenous neuroprotection in glaucoma","volume":"19","author":"Chou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib46","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1172\/JCI91948","article-title":"Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucoma","volume":"127","author":"Akopian","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ophtha.2018.06.017_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112418","article-title":"The small heat shock protein alpha-crystallin B shows neuroprotective properties in a glaucoma animal model","volume":"18","author":"Anders","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib48","first-page":"289","article-title":"microRNA-21a-5p\/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma","volume":"9","author":"Su","year":"2017","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.ophtha.2018.06.017_bib49","series-title":"New Trends in Basic and Clinical Research in Glaucoma: A Neurodegenerative Disease of the Visual System\u2014Part B","first-page":"135","article-title":"How to detect progression in glaucoma","author":"Vianna","year":"2015"},{"key":"10.1016\/j.ophtha.2018.06.017_bib50","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/brain\/awx088","article-title":"Real-time imaging of single neuronal cell apoptosis in patients with glaucoma","volume":"140","author":"Cordeiro","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ophtha.2018.06.017_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168565","article-title":"Exploring serum levels of brain derived neurotrophic factor and nerve growth factor across glaucoma stages","volume":"12","author":"Oddone","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2018.06.017_bib52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/02713683.2016.1217544","article-title":"Retinal oxygen saturation in patients with primary open-angle glaucoma using a non-flash hyperspectral camera","volume":"42","author":"Shahidi","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2018.06.017_bib53","doi-asserted-by":"crossref","first-page":"BI0227","DOI":"10.1167\/iovs.17-21776","article-title":"Retinal oximetry discovers novel biomarkers in retinal and brain diseases","volume":"58","author":"Stefansson","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.06.017_bib54","doi-asserted-by":"crossref","first-page":"25792","DOI":"10.1038\/srep25792","article-title":"Association between systemic oxidative stress and visual field damage in open-angle glaucoma","volume":"6","author":"Tanito","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ophtha.2018.06.017_bib55","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1167\/iovs.15-17286","article-title":"Retinotopic changes in the gray matter volume and cerebral blood flow in the primary visual cortex of patients with primary open-angle glaucoma","volume":"56","author":"Zhang","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018300290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018300290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:06:23Z","timestamp":1758981983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642018300290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0161642018300290"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.06.017","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Memantine for the Treatment of Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/>http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/<\/inter-ref>).","name":"copyright","label":"Copyright"}]}}